表紙
市場調查報告書

質子治療的日本市場:各癌症種類的患者數·償付政策·治療患者數

Japan Proton Therapy Market, Patients by 10 Cancer Types(CNS, Head and Neck, Lung, GI, HCC, Pancreas, Gynecologic, Prostate, etc.), Reimbursement Policies & Persons Treated at Centers

出版商 Renub Research 商品編碼 427205
出版日期 內容資訊 英文 105 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
質子治療的日本市場:各癌症種類的患者數·償付政策·治療患者數 Japan Proton Therapy Market, Patients by 10 Cancer Types(CNS, Head and Neck, Lung, GI, HCC, Pancreas, Gynecologic, Prostate, etc.), Reimbursement Policies & Persons Treated at Centers
出版日期: 2019年09月01日內容資訊: 英文 105 Pages
簡介

本報告提供日本的質子治療的市場調查,彙整實際的市場與潛在市場規模的變化與預測,實際患者數和潛在患者數的變化與預測,各癌症種類的市場規模·患者數的變化與預測,償付政策,標準的質子治療中心的設備,主要企業分析,市場成長的促進因素·課題分析等資料。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場變化與預測

  • 實際的市場
  • 潛在市場

第5章 患者數的變化與預測

  • 實際的患者數
  • 潛在的患者數

第6章 患者數的變化與預測:各癌症類型

  • 中樞神經系統 (CNS) 腫瘤
  • 頭頸椎癌症
  • 肺癌
  • 消化器官 (GI) 癌症
  • 肝細胞 (HCC) 癌症
  • 胰臟癌
  • 婦產科腫瘤
  • 前列腺癌
  • 骨腫瘤·軟組織腫瘤
  • 其他

第5章 市場變化與預測:各癌症類型

  • 中樞神經系統 (CNS) 腫瘤
  • 頭頸椎癌症
  • 肺癌
  • 消化器官 (GI) 癌症
  • 肝細胞 (HCC) 癌症
  • 胰臟癌
  • 婦產科腫瘤
  • 前列腺癌
  • 骨腫瘤·軟組織腫瘤
  • 其他

第6章 質子治療中心的清單

  • 運作中
  • 建設中

第7章 治療中的患者數的轉變:各中心

  • 國立癌症中心東醫院
  • 兵庫縣立粒子線醫療中心
  • 筑波大學質子線醫學利用研究中心
  • 若狹灣能源研究中心
  • 靜岡縣立癌症中心
  • 南東北癌症質子治療中心
  • Medipolis國際質子治療中心
  • 福井縣質子線癌症治療中心
  • 名古屋質子治療中心
  • 九州國際重粒子線癌症治療中心
  • 相澤醫院質子治療中心
  • 北海道大學醫院質子治療中心

第8章 償付政策

第9章 標準的質子治療中心的設備

  • 質子加速器
    • 同步加速器 (案例:LLUMC at Loma Linda)
    • 迴旋加速器 (案例:MGH Boston)
    • 同步迴旋加速器 (案例:Orsay·Uppsala)
    • Linac (線型粒子加速設備)
    • H虧損同步加速器
    • 分離扇迴旋加速器
    • 超導性迴旋加速器
    • 高速旋轉迴旋加速器
  • 電子束運輸系
  • 射束傳送系統
    • 被動散射體法
    • 電子束掃描
  • 管嘴
    • 單一散射
    • 多重散射
    • 均勻掃描
    • 筆形掃描
  • 治療規劃系統
  • 影像放映裝置
  • 患者定位系統 (PPS)
  • 人力資源

第10章 企業分析

  • IBA Proton Therapy
  • Varian Medical Systems
  • Elekta

第11章 質子治療:促進要素

  • 技術進步
  • 日本癌症患者的發生率增加

第12章 質子治療:課題

  • 大規模投資的必要性
  • 營運上的課題

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

In Japan, the University of Tsukuba started clinical research and development in the year 1983. This was the first university in Japan that facilitates research and development of proton therapy and it created various milestones at various levels like started treatment of multiple cancerous tumors and creating a worldwide standard of proton therapy etc. In Japan, the number of patients eligibility for proton therapy is much higher than the proton therapy center, which treated the patients. According to our research, Japan is the largest proton therapy hub in Asia. The Japan Proton Therapy Market potential is expected to cross US$ 6 Billion by the end of the year 2025.

Rising cancer prevalence, increasing aging population, growing per capita expenditure, increasing number of proton therapy center in Japan will further boost the proton therapy market in the future course of time. In the early time, proton therapy was used to treat specific kind of cancers like prostate, CNS etc. but now proton therapy technology can treat various cancer at every stage of life; from pediatric to adult and old age also.

Patients Insight - Japan Proton Therapy

This report contains full information about patients, who are likely to get treated with proton therapy, the actual number of patients who have received proton therapy treatment. Moreover we have also categorized the patients on the basis of disease or cancer type into 10 parts; Head and Neck Cancer, Central Nervous System (CNS) Tumors, GI (Gastro-Intestinal) Cancer, Hepatocellular Carcinoma (HCC), Pancreas Cancer, Prostate Cancer, Lung Cancer, Gynecologic Cancers, Bone and Soft Tissue Cancer, Others). We have also provided an in-depth analysis of proton therapy center in Japan, providing a treated patient number by each year and by each operational center in Japan.

Market Insight - Japan Proton Therapy

Japan is one of the largest hubs of proton therapy center in the Asian region. The rising technological development and increasing cutting-edge technology in radiotherapy in Japan will further propel the proton therapy market of Japan in the forecast period. Currently, Japan has XXXX operational proton therapy center and XXXX new under-constructional phase proton therapy center project. The rising new under-contraction proton therapy center in Japan due to cancer patient in Japan is increasing at a rapid pace, and it will continue in the future course of time.

Renub Research report “Japan Proton Therapy Market, Patients by 10 Cancer Types (Central Nervous System (CNS), Head and Neck, Lung, GI (Gastro-Intestinal), Hepatocellular Carcinoma (HCC), Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others) Reimbursement Policies & Persons Treated at Centers” provides a comprehensive assessment of the fast-evolving, high-growth of Japan Proton Therapy Market.

The report studies the market and patients numbers, of 10 individual cancer types who are treated under proton therapy. The report also talks about the list of all operational and future Proton Therapy centers; Reimbursement Policies. The report also studies the Proton Therapy Revenue of 3 Companies.

Types of Proton Therapy Market (Actual & Untapped)

  • 1. Actual Market is the current market which is already present.
  • 2. Untapped Market is the market which can be achieved, but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

Japan Proton Therapy Market has been analyzed from six viewpoints

  • 1. Actual Market
  • 2. Potential Market
  • 3. Treated Patient Numbers
  • 4. Untapped Patient Numbers
  • 5. Cancer Type - Japan Proton Therapy Market
  • 6. Cancer Type - Japan Proton Therapy Number of Patients

10 Types of Cancer Patient Numbers and Market in Japan Proton Therapy

  • 1. Central Nervous System (CNS) Tumors
  • 2. Head and Neck Cancer
  • 3. Prostate Cancer
  • 4. Lung Cancer
  • 5. GI (Gastro-Intestinal) Cancer
  • 6. Hepatocellular Carcinoma (HCC) Cancer
  • 7. Pancreas Cancer
  • 8. Gynecologic Cancers
  • 9. Bone and Soft Tissue Cancer
  • 10. Others Cancer

Key Companies Covered:

  • 1. IBA (Overview, Sales Analysis)
  • 2. Varian Medical Systems (Overview, Sales Analysis)
  • 3. Elekta (Overview, Sales Analysis)

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market (Actual & Untapped) - Japan Proton Therapy (2009 - 2025)

  • 4.1. Actual Proton Therapy Market
  • 4.2. Untapped Proton Therapy Market

5. Number of Patients - Japan Proton Therapy (2009 - 2025)

  • 5.1. Actual Numbers
  • 5.2. Untapped Numbers

6. Cancer Types - Japan Proton Therapy Number of Patients (2009 - 2025)

  • 6.1. Central Nervous System (CNS) Tumors
  • 6.2. Head and Neck Cancer
  • 6.3. Lung Cancer
  • 6.4. GI (Gastro-Intestinal) Cancer
  • 6.5. Hepatocellular Carcinoma (HCC) Cancer
  • 6.6. Pancreas Cancer
  • 6.7. Gynecologic Cancers
  • 6.8. Prostate Cancer
  • 6.9. Bone and Soft Tissue Cancer
  • 6.10. Others Cancer

7. Cancer Types - Japan Proton Therapy Market (2009 - 2025)

  • 7.1. Central Nervous System (CNS) Tumors
  • 7.2. Head and Neck Cancer
  • 7.3. Lung Cancer
  • 7.4. GI (Gastro-Intestinal) Cancer
  • 7.5. Hepatocellular Carcinoma (HCC) Cancer
  • 7.6. Pancreas Cancer
  • 7.7. Gynecologic Cancers
  • 7.8. Prostate Cancer
  • 7.9. Bone and Soft Tissue Cancer
  • 7.10. Others Cancer

8. Japan - List of Proton Therapy Centers

  • 8.1. Operating Proton Therapy Centers
  • 8.2. Under-Construction Therapy Centers

9. By Centers - Number of Proton Therapy Patients Treated

  • 9.1. Kashiwa (NCC) Proton Therapy Center (2008 - 2016)
  • 9.2. Hyogo (HIBMC) Proton Therapy Center (2008 - 2016)
  • 9.3. Tsukuba (PMRC, 2) Proton Therapy Center (2008 - 2016)
  • 9.4. WERC Proton Therapy Center (2008 - 2009)
  • 9.5. Shizuoka Proton Therapy Center (2008 - 2016)
  • 9.6. Koriyama-City Proton Therapy Center (2008 - 2016)
  • 9.7. Ibusuki (MMRI) Proton Therapy Center (2011 - 2016)
  • 9.8. Fukui City (Prefectural Hospital) Proton Therapy Center (2013 - 2015)
  • 9.9. Nagoya PTC, Nagoya, Aichi Proton Therapy Center (2013 - 2016)
  • 9.10. Tosu (Saga-HIMAT) Proton Therapy Center (2013)
  • 9.11. Nagano Proton Therapy Center (2014 - 2016)
  • 9.12. Hokkaido Proton Therapy Center (2014 - 2016)

10. Reimbursement Policies - Japan Proton Therapy

11. Components of a Standard Proton Therapy Center

  • 11.1. Type of Proton Accelerator
    • 11.1.1. Synchrotrons (example: LLUMC at Loma Linda)
    • 11.1.2. Cyclotrons (example: MGH Boston)
    • 11.1.3. Synchrocyclotrons (examples: Orsay, Uppsala)
    • 11.1.4. Linacs (Rome)
    • 11.1.5. H-minus Synchrotrons
    • 11.1.6. Separated Sector Cyclotrons
    • 11.1.7. Super-conducting Cyclotrons
    • 11.1.8. Fast Cycling Synchrotron
  • 11.2. Beam Transport System
  • 11.3. Beam Delivery System
    • 11.3.1. The Passive Scattering Technique
    • 11.3.2. Beam Scanning
  • 11.4. Type of Nozzle
    • 11.4.1. Single Scattering
    • 11.4.2. Double Scattering
    • 11.4.3. Uniform Scanning Nozzle
    • 11.4.4. Pencil Scanning Nozzle
  • 11.5. Treatment Planning System
  • 11.6. Image Viewers
  • 11.7. Patient Positioning System (PPS)
  • 11.8. Human Resource

12. Company Analysis (2014 - 2025)

  • 12.1. IBA Proton Therapy
    • 12.1.1. Sales Analysis
  • 12.2. Varian Medical Systems
    • 12.2.1. Sales Analysis
  • 12.3. Elekta
    • 12.3.1. Sales Analysis

13. Proton Therapy - Driving Factors

  • 13.1. Technology Advancement
    • 13.1.1. Next-Generation Proton Technique
  • 13.2. Growing Incidence of Cancer Patients in Japan

14. Challenges

  • 14.1. Requires Huge Investment
  • 14.2. Operation Challenges

List of Figures

  • Figure 2-1: Japan - Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-2: Japan - Forecast for Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 2-3: Japan - Untapped Proton Therapy Market (Million US$), 2009 - 2018
  • Figure 2-4: Japan - Forecast for Untapped Proton Therapy Market (Million US$), 2019 - 2025
  • Figure 3-1: Japan - Patient Treated with Proton Therapy (Number), 2009 - 2018
  • Figure 3-2: Japan - Forecast for Patient Treated with Proton Therapy (Number), 2019 - 2025
  • Figure 3-3: Japan - Untapped Patients for Proton Therapy (Number), 2009 - 2018
  • Figure 3-4: Japan - Forecast for Untapped Patients for Proton Therapy (Number), 2019 - 2025
  • Figure 4-1: Japan - Proton Therapy Patients by CNS (Number), 2009 - 2018
  • Figure 4-2: Japan - Forecast for Proton Therapy Patients by CNS (Number), 2019 - 2025
  • Figure 4-3: Japan - Proton Therapy Patients by Head and Neck (Number), 2009 - 2018
  • Figure 4-4: Japan - Forecast for Proton Therapy Patients by Head and Neck (Number), 2019 - 2025
  • Figure 4-5: Japan - Proton Therapy Patients by Lung Cancer (Number), 2009 - 2018
  • Figure 4-6: Japan - Forecast for Proton Therapy Patients by Lung Cancer (Number), 2019 - 2025
  • Figure 4-7: Japan - Proton Therapy Patients by GI Cancer (Number), 2009 - 2018
  • Figure 4-8: Japan - Forecast for Proton Therapy Patients by GI Cancer (Number), 2019 - 2025
  • Figure 4-9: Japan - Proton Therapy Patients by HCC (Number), 2009 - 2018
  • Figure 4-10: Japan - Forecast for Proton Therapy Patients by HCC (Number), 2019 - 2025
  • Figure 4-11: Japan - Proton Therapy Patients by Pancreas (Number), 2009 - 2018
  • Figure 4-12: Japan - Forecast for Proton Therapy Patients by Pancreas (Number), 2019 - 2025
  • Figure 4-13: Japan - Proton Therapy Patients by Gynecologic Cancer (Number), 2009 - 2018
  • Figure 4-14: Japan - Forecast for Proton Therapy Patients by Gynecologic Cancer (Number), 2019 - 2025
  • Figure 4-15: Japan - Proton Therapy Patients by Prostate Cancer (Number), 2009 - 2018
  • Figure 4-16: Japan - Forecast for Proton Therapy Patients by Prostate Cancer (Number), 2019 - 2025
  • Figure 4-17: Japan - Proton Therapy Patients by Bone and Soft Tissue (Number), 2009 - 2018
  • Figure 4-18: Japan - Forecast for Proton Therapy Patients by Bone and Soft Tissue (Number), 2019 - 2025
  • Figure 4-19: Japan - Proton Therapy Patients by Others (Number), 2009 - 2018
  • Figure 4-20: Japan - Forecast for Proton Therapy Patients by Others (Number), 2019 - 2025
  • Figure 5-1: Japan - Proton Therapy Market by CNS (Million US$), 2009 - 2018
  • Figure 5-2: Japan - Forecast for Proton Therapy Market by CNS (Million US$), 2015 - 2025
  • Figure 5-3: Japan - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2018
  • Figure 5-4: Japan - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2019 - 2025
  • Figure 5-5: Japan - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2018
  • Figure 5-6: Japan - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2019 - 2025
  • Figure 5-7: Japan - Proton Therapy Market by GI Cancer (Million US$), 2009 - 2018
  • Figure 5-8: Japan - Forecast for Proton Therapy Market by GI Cancer (Million US$), 2019 - 2025
  • Figure 5-9: Japan - Proton Therapy Market by HCC (Million US$), 2009 - 2018
  • Figure 5-10: Japan - Forecast for Proton Therapy Market by HCC (Million US$), 2019 - 2025
  • Figure 5-11: Japan - Proton Therapy Market by Pancreas (Million US$), 2009 - 2018
  • Figure 5-12: Japan - Forecast for Proton Therapy Market by Pancreas (Million US$), 2019 - 2025
  • Figure 5-13: Japan - Proton Therapy Market by Gynecologic cancers (Million US$), 2009 - 2018
  • Figure 5-14: Japan - Forecast for Proton Therapy Market by Gynecologic cancers (Million US$), 2019 - 2025
  • Figure 5-15: Japan - Proton Therapy Market by Prostate cancers (Million US$), 2009 - 2018
  • Figure 5-16: Japan - Forecast for Proton Therapy Market by Prostate cancers (Million US$), 2019 - 2025
  • Figure 5-17: Japan - Proton Therapy Market by Bone and Soft Tissue (Million US$), 2009 - 2018
  • Figure 5-18: Japan - Forecast for Proton Therapy Market by Bone and Soft Tissue (Million US$), 2019 - 2025
  • Figure 5-19: Japan - Proton Therapy Market by Others (Million US$), 2009 - 2018
  • Figure 5-20: Japan - Forecast for Proton Therapy Market by Others (Million US$), 2019 - 2025
  • Figure 10-1: Global - IBA Proton Therapy Sales (Million USD), 2014 - 2018
  • Figure 10-2: Global - Forecast for IBA Proton Therapy Sales (Million USD), 2019 - 2025
  • Figure 10-3: Global - Varian Medical Systems Oncology Systems Sales (Million USD), 2014 - 2018
  • Figure 10-4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million USD), 2019 - 2025
  • Figure 10-5: Global - Elekta Revenue, (Million USD), 2014 - 2018
  • Figure 10-6: Global - Forecast for Elekta Revenue (Million USD), 2019 - 2025
  • Figure 11-1: Japan - Number of Patient Diagnosed With Cancer (Thousand), 2014 - 2018
  • Figure 11-2: Japan - Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2019 - 2025

List of Tables:

  • Table 6-1: Japan - Proton Therapy Centers in Operation
  • Table 6-2: Japan - Proton Therapy Centers in Under-Construction
  • Table 7-1: Japan - Kashiwa (NCC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-2: Japan - Hyogo (HIBMC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-3: Japan - Tsukuba (PMRC, 2) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-4: Japan - WERC Proton Therapy Center with Patients Treated (Number), 2008 - 2009
  • Table 7-5: Japan - Shizuoka Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7-6: Japan - Koriyama-City Proton Therapy Center with Patients Treated (Number), 2011 - 2016
  • Table 7-7: Japan - Ibusuki (MMRI) Proton Therapy Center with Patients Treated (Number), 2011 - 2016
  • Table 7-8: Japan - Fukui City (Prefectural Hospital) Proton Therapy Center with Patients Treated (Number), 2013 - 2015
  • Table 7-9: Japan - Nagoya PTC, Nagoya, Aichi Proton Therapy Center with Patients Treated (Number), 2013 - 2016
  • Table 7-10: Japan - Tosu (Saga-HIMAT) Proton Therapy Center with Patients Treated (Number), 2013
  • Table 7-11: Japan - Nagano Proton Therapy Center with Patients Treated (Number), 2014 - 2016
Back to Top